245 related articles for article (PubMed ID: 20551097)
21. [Electrocardiographic disorders in diverse clinical variations of scleroderma].
Targa L; Cardin G; Cozzi F; Glorioso S; Rossi L; Todesco S
G Clin Med; 1990 Jan; 71(1):17-24. PubMed ID: 2142111
[TBL] [Abstract][Full Text] [Related]
22. [Character of synovial fluid in systemic sclerosis (scleroderma)].
Hüttl S; Hüttlová O
Vnitr Lek; 1971 May; 17(5):436-45. PubMed ID: 5162705
[No Abstract] [Full Text] [Related]
23. Articular involvement in systemic sclerosis.
Avouac J; Clements PJ; Khanna D; Furst DE; Allanore Y
Rheumatology (Oxford); 2012 Aug; 51(8):1347-56. PubMed ID: 22467084
[TBL] [Abstract][Full Text] [Related]
24. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
[TBL] [Abstract][Full Text] [Related]
25. Scleroderma--developing measures of response.
Furst DE; Khanna D; Mattucci-Cerinic M; Silman AJ; Merkel PA; Foeldvari I;
J Rheumatol; 2005 Dec; 32(12):2477-80. PubMed ID: 16331791
[TBL] [Abstract][Full Text] [Related]
26. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
27. The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma).
RODNAN GP
Ann Intern Med; 1962 Mar; 56():422-39. PubMed ID: 14493143
[No Abstract] [Full Text] [Related]
28. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
Johnson SR; Glaman DD; Schentag CT; Lee P
J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
[TBL] [Abstract][Full Text] [Related]
29. Relationship between occupational risk factors and severity markers of systemic sclerosis.
Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
31. Localized scleroderma in childhood is not just a skin disease.
Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging of the hand in systemic sclerosis.
Low AH; Lax M; Johnson SR; Lee P
J Rheumatol; 2009 May; 36(5):961-4. PubMed ID: 19332637
[TBL] [Abstract][Full Text] [Related]
33. Relationship between functional capacity, joint mobility and pulmonary function in patients with systemic sclerosis.
Lima TR; Guimarães FS; Silva LA; Silva DP; Menezes SL; Lopes AJ
J Bodyw Mov Ther; 2015 Jan; 19(1):17-24. PubMed ID: 25603740
[TBL] [Abstract][Full Text] [Related]
34. Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
Walker KM; Pope J; ;
J Rheumatol; 2011 Jul; 38(7):1326-8. PubMed ID: 21459952
[TBL] [Abstract][Full Text] [Related]
35. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
Follansbee WP; Miller TR; Curtiss EI; Orie JE; Bernstein RL; Kiernan JM; Medsger TA
J Rheumatol; 1990 May; 17(5):656-62. PubMed ID: 2359076
[TBL] [Abstract][Full Text] [Related]
36. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis.
Thombs BD; Hudson M; Taillefer SS; Baron M;
Arthritis Rheum; 2008 Apr; 59(4):504-9. PubMed ID: 18383422
[TBL] [Abstract][Full Text] [Related]
38. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
Ingegnoli F; Carmona L; Castrejon I
Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
[TBL] [Abstract][Full Text] [Related]
39. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
40. Hand impairment in systemic sclerosis: association of different hand indices with organ involvement.
Ingegnoli F; Boracchi P; Ambrogi F; Gualtierotti R; Galbiati V; Meroni PL
Scand J Rheumatol; 2010; 39(5):393-7. PubMed ID: 20476855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
